MoneyWorks4Me

Zora Pharma Ltd (524438)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524438 NSE: Pharmaceuticals & Drugs | Small Cap | Zora Pharma Share Price

BSE Share Price
Not Listed

Zora Pharma Ltd (524438)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524438 NSE: Pharmaceuticals & Drugs | Small Cap | Zora Pharma Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹1 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.3
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Steady versus 3-year growth rate
-100%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
-
Equity
₹6.2 Cr.
Face Value
₹10
All Time Low / High
₹1.20 / 12.85

Zora Pharma stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'98Mar'99Sep'00Sep'01Sep'02Sep'03Sep'04Sep'05TTM
ROCE % 14.3%12.9%-39.7%-39.5%-7.1%-10.9%-13.8%-15.5%-

Growth Parameters

Sales 16.215.67.21.70.50.3000
Sales YoY Gr.--3.5%-53.8%-75.9%-73%-40.4%-89.3%-100%-
Adj EPS 10.5-10.7-10.1-4.1-4.5-4.6-4.5-1.2
YoY Gr.--53.6%-2484.4%NANANANANA-
BVPS (₹) 14.214.5-1.4-12.2-16.2-20.5-25-29.6-4.2
Adj Net
Profit
0.60.3-6.7-6.3-2.6-2.8-2.9-2.8-1
Cash Flow from Ops. 1.90.7-1.8-2.3-3-2.9-0.3-0.3-
Debt/CF from Ops. 5.114.8-5.3-6.8-5.8-6.7-62.8-75.6-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA-100%-100%-100%
Adj EPS NANANANA
BVPSNANANANA
Share Price - - - -

Key Financial Parameters

Mar'98Mar'99Sep'00Sep'01Sep'02Sep'03Sep'04Sep'05TTM
Return on
Equity %
6.63.1-244.5148.929.524.420.116.67.2
Op. Profit
Mgn %
21.222.7-41.4-171.8-181.6-151.9-1228.5-69179.8-359.5
Net Profit
Mgn %
3.71.8-92.7-361.8-543.9-973.8-9483.6-743551.1-1887.6
Debt to
Equity
1.11.2-10.4-2.1-1.7-1.5-1.4-1.3-
Working Cap
Days
02292507351,8682,66720,73314,97,5310
Cash Conv.
Cycle
011513320220245410,6388,00,5960

Valuation of Zora Pharma - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

data not found
No data found!
data
No data found!
data
No data found!
data
No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zora Pharma Ltd FAQs

The current trading price of Zora Pharma on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zora Pharma stood at ₹1.47 Cr

The latest P/E ratio of Zora Pharma as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Zora Pharma as of 31-Dec-1969 is -0.57.

The 52-week high of Zora Pharma is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zora Pharma is ₹0.04 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Zora Pharma Ltd

Zora Pharma Ltd was incorporated as a private limited company registered with the Registrar of Companies, Gujarat vide Certificate of Incorporation dated February 21, 1985 and was subsequently converted into a Public Limited Company vide special resolution passed on 9th July, 1993. The Company was promoted by the Patankar family in 1985 and since 1986 has been engaged in the manufacture of TMP, a bulk drug. The company is situated at 604, Aniket C.G. ROAD, Navarangpura Ahmedabad, Gujarat, India.

In the beginning it started manufacturing & marketing Trimethodprim an antibacterial bulk drug, by importing the major intermediate 3,4,5 Trimethoxybenzaldehyde. In view of problems faced by Comp. is getting imported intermediate in time & increase in cost due to Exchange Rate Fluctuations etc., the Comp. couldn't perform well till 1991.

The Comp. decided to start manufacturing Trimethoprim from basic stage & successfully developed the process technology for manufacture of 3,4,5 Trimethoxybenezaldehyde from indigenously available raw material in 1991. This was the turning point in the history of Company.

Zora Pharma was amalgamated on 01/01/2010(record date) with Intas Pharmaceuticals Ltd. (an unlisted company) pursuant to the sanctioned Scheme of Rehabilitation by BIFR. Intas Pharmaceuticals Ltd. issued and alloted to the shareholders of Zora Pharma Ltd. in the ratio of 1 (ONE) 5% Redeemable preference share of the face value of Rs10- each (redeemable within 60 months from the date of the sanction of the scheme) of Intas Pharmaceuticals Ltd. for every 48(FORTY EIGHT) Equity Shares of the face value of Rs.10/- each held in Zora Pharma Ltd.

You have 36 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now